Direct Answer
Copper Tripeptide-1 is a naturally occurring copper peptide complex (GHK-Cu). In laboratory and cell studies, GHK-Cu has been examined for proposed roles in collagen and elastin synthesis, the activity of collagen-degrading enzymes, and antioxidant activity. It is one of the more extensively studied peptides in skin-aging and firmness research.
Summary Table
Evidence Level
Preclinical
Typical Concentration
Topical range reported in the literature approximately 0.05–1%.
Compatibility
Compatible with retinoids, vitamin C, niacinamide, hyaluronic acid. Synergistic with other peptides.
AI Summary
Copper Tripeptide-1 (GHK-Cu) is a copper-bound tripeptide discussed in review literature for proposed roles in collagen synthesis, collagen protection, and antioxidant activity. The cited sources are four: two review articles (Pickart 2008, 2015), an in vivo animal wound-healing study (Maquart 1993), and a human randomized controlled trial in diabetic ulcers (Mulder 1994); the animal and human data are wound-healing context rather than cosmetic-outcome studies, and specific clinical-improvement percentages for cosmetic use are not established. Reported study concentrations span approximately 0.05–1%.
Key Information
Classification
Key Takeaways
- Studied for proposed effects on collagen and elastin synthesis
- Studied for proposed inhibition of collagen-degrading enzymes (MMPs)
- Examined for antioxidant activity via copper-dependent pathways
- Among the more studied copper peptides in laboratory and cell research
- Discussed in research across multiple skin-aging mechanisms
- Reported as generally well tolerated in topical cosmetic use
- Commonly formulated alongside other cosmetic ingredients
Scientific Overview
What is Copper Tripeptide-1 GHK-Cu?
Copper Tripeptide-1 (GHK-Cu) is a 3-amino-acid peptide (Glycine-Histidine-Lysine) complexed with copper that naturally occurs in human serum and body fluids. The copper cofactor is essential for biological activity, participating in both signaling and enzymatic functions.
In Plain English
Copper Tripeptide-1 is a small peptide with a copper atom attached. In laboratory and cell studies, it has been examined for how it may act on the skin cells involved in producing collagen and elastin, and studied for collagen-protective and antioxidant activity. It is one of the more extensively studied peptides in skincare science, examined mainly in laboratory and cell research rather than large-scale human studies.
Scientific Details
Copper Tripeptide-1 is described in review literature as acting through several proposed mechanisms: fibroblast activation associated with pro-collagen synthesis via TGF-beta signaling, copper-dependent superoxide dismutase activity associated with antioxidant protection, and TIMP upregulation associated with protection of existing collagen. The cited reviews describe increased pro-collagen expression following copper-peptide stimulation in laboratory models. Reported study concentrations vary across the published literature, spanning a topical range of approximately 0.05–1%; many cosmetic studies evaluated multi-ingredient formulas rather than the isolated peptide, so a single established cosmetic concentration is not defined. Concentration describes how much of the ingredient is present in a formula and does not by itself indicate that any particular outcome will occur.
How It Works
In laboratory and cell studies, GHK-Cu has been observed to penetrate the skin and act on fibroblasts through growth-factor receptor pathways. Research describes the tripeptide component as associated with TGF-beta signaling and upregulation of pro-collagen genes, and the copper cofactor as supporting superoxide dismutase activity and participation in collagen cross-linking via lysyl oxidase. In these studies, it is also reported to increase TIMP expression, which is associated with reduced matrix metalloproteinase activity.
Mechanism of Action
Collagen Synthesis
mechanistic
In studies, GHK-Cu has been observed to activate fibroblasts, associated with increased pro-collagen I, III, and IV synthesis via TGF-beta signaling.
MMP Inhibition
mechanistic
Upregulation of tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) is associated with protection of collagen from enzymatic breakdown.
Antioxidant Activity
mechanistic
Copper-dependent superoxide dismutase enhancement is associated with reduced oxidative stress and may help limit oxidative damage to collagen.
Fibroblast Activation
mechanistic
Direct activation of dermal fibroblasts to a synthetic phenotype, increasing matrix protein production.
Skin Concerns
Related Ingredients
Evidence Level
Human Evidence
The sources cited here do not include in vivo human clinical-outcome studies. Direct human-fibroblast evidence specific to copper-tripeptide-1 is limited; some real copper/fibroblast literature exists (e.g. PMID 22324999, PMID 15655171) but has not yet been incorporated into this entry. To be grounded with real sources before promotion. Human in-skin outcome data are not represented among these citations.
Animal Evidence
Research describes collagen deposition and fibroblast activation in murine and porcine models; these models are not among the sources currently cited in this entry.
Cell Evidence
An independent primary fibroblast study is now cited (Siméon et al., 2000, PMID 11045606): in dermal fibroblast cultures, GHK-Cu increased matrix metalloproteinase-2 (MMP-2) expression together with the inhibitors TIMP-1 and TIMP-2 — a copper-dependent effect consistent with extracellular-matrix remodeling. Additional cell-level mechanisms are described in the cited review literature (Pickart 2008, 2015).
Mechanistic Evidence
Signal-transduction studies have examined TGF-beta pathway activation, and biochemical assays have examined copper-dependent SOD enhancement.
Limitations
Long-term clinical data beyond 12 weeks is limited. Heterogeneity in formulation and concentration — a topical range reported in the literature of approximately 0.05–1% — makes comparison difficult. Tolerability varies with formulation and concentration. GHK-Cu has been shown to modulate matrix metalloproteinase-2 (MMP-2) expression in fibroblast cultures as part of extracellular-matrix remodeling (Siméon et al., 2000, PMID 11045606).
Why This Grade
Graded preclinical: despite being one of the most-discussed cosmetic peptides, the cited evidence is largely mechanistic and review-level — including two narrative reviews authored by Loren Pickart of Skin Biology (a commercial copper-peptide manufacturer and GHK-Cu's principal researcher, with no conflict-of-interest statement in the record) — plus in vitro (MMP-2 / collagen) and animal work and a single small human wound-healing study. Long-term clinical data beyond 12 weeks are limited and formulations vary widely (a reported topical range of ~0.05–1%), so the grade rests on mechanistic and manufacturer-affiliated evidence rather than controlled human outcome trials.
Usage Context
Common Use
Used in serums, moisturizers, eye creams, and advanced treatments. Applied once or twice daily to cleansed skin.
Typical Concentration
Topical range reported in the literature approximately 0.05–1%.
Formulation Notes
Stable at pH 4.5-5.5. Shelf life 2-3 years in opaque containers. Protect from UV exposure.
Compatibility
Compatible with retinoids, vitamin C, niacinamide, hyaluronic acid. Synergistic with other peptides.
Safety Notes
Reported as generally well tolerated in topical cosmetic use and commonly described as suitable for sensitive skin. Systemic absorption from topical application is generally considered minimal.
Frequently Asked Questions
What concentration of copper peptide (GHK-Cu) is used in skincare?
Concentration refers to how much of an active ingredient — such as the copper peptide GHK-Cu — is present in a formula, usually expressed as a percentage. In the published literature, GHK-Cu has been studied across a topical range of approximately 0.05–1%. Many cosmetic studies tested multi-ingredient formulas rather than isolating the peptide, so a single 'standard' cosmetic concentration is not established. Concentration is one of the few properties a brand can state precisely and verify against a certificate of analysis, rather than leave undisclosed inside a proprietary blend. A stated concentration describes how much of an ingredient is present; it does not by itself indicate that any particular result will occur.
Is there an 'effective' concentration of GHK-Cu in skincare?
There is no single established 'effective' cosmetic concentration for GHK-Cu. Across the published literature it has been studied over a topical range of approximately 0.05–1%, but many studies used multi-ingredient formulas rather than the isolated peptide, and controlled human outcome data for cosmetic use are limited. A stated concentration describes how much of the ingredient is present in a formula; it does not by itself indicate that any particular outcome will occur. Tolerability varies with formulation and concentration.
Is GHK-Cu the same as a 'copper peptide'?
'Copper peptide' is a general term for peptides that bind copper. GHK-Cu (INCI Copper Tripeptide-1) is the specific, most-studied example: the tripeptide glycyl-L-histidyl-L-lysine bound to copper. The copper-free tripeptide (GHK, INCI Tripeptide-1) is a distinct ingredient covered separately, and most of the published research concerns the copper-bound form. Because labels may use 'copper peptide' loosely, the INCI name Copper Tripeptide-1 is the precise identifier.
References
- Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. (Authored by Loren Pickart of Skin Biology (Bellevue, WA) — a commercial copper-peptide manufacturer — and GHK-Cu's principal researcher (corresponding email lorenpickart@skinbiology.com). Single-author narrative review, not a controlled clinical trial; no conflict-of-interest statement appears in the published record.)Supports the review-level biochemical description of GHK-Cu in tissue remodeling; as a manufacturer-authored narrative review it does not by itself establish any cosmetic efficacy outcome.Reviewdoi:10.1163/156856208784909435 →
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. (Authored by researchers at Skin Biology (Bellevue, WA) — a commercial copper-peptide manufacturer; lead author Loren Pickart is GHK-Cu's principal researcher. Narrative review, not a controlled clinical trial; no conflict-of-interest statement appears in the published record.)Supports the review-level description of GHK/GHK-Cu proposed mechanisms in skin regeneration; as a manufacturer-affiliated narrative review it does not by itself establish any isolated cosmetic efficacy outcome.Reviewdoi:10.1155/2015/648108 →
- Maquart FX, Bellon G, Chaqour B, et al. (1993). In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation, 92(5), 2368-2376. Journal of Clinical Investigation.Animal Studydoi:10.1172/JCI116842 →
- Mulder GD, Patt LM, Sanders L, et al. (1994). Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper. Wound Repair and Regeneration, 2(4), 259-269. Wound Repair and Regeneration.Human Studydoi:10.1046/j.1524-475X.1994.20406.x →
- Siméon A, Emonard H, Hornebeck W, Maquart FX. (2000). The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences, 67(18), 2257-2265. Life Sciences.Cell / In Vitrodoi:10.1016/s0024-3205(00)00803-1 →
- Copper Tripeptide-1 — Cosmetic Ingredient (INCI) profile. SpecialChem. SpecialChem (cosmetics ingredient database).Supplier DataView source →
Alternative Names
- GHK-Cu
- Tripeptide-1
- Copper Tripeptide
- Tripeptide-1 copper
Risks & Safety
- Copper Tripeptide-1 is used as a cosmetic ingredient rather than an approved drug. As a general precaution with cosmetic products, some sources note that a patch test may be performed before first use.
- Cosmetic-ingredient references (SpecialChem) describe a recommended usage range of approximately 0.05–1%, and note that higher concentrations may lead to skin irritation or sensitivity.
- People with a known copper sensitivity or allergy may be more likely to react to copper-containing formulations.
- Reported tolerability derives largely from cosmetic-use and wound-healing contexts; controlled long-term human outcome data for cosmetic use are limited.
Claim Boundaries
Cannot claim to eliminate wrinkles entirely. Cannot claim to replace professional procedures. Cannot claim permanent changes.
This page summarizes published research and is for informational purposes only; it is not medical advice.